Back to search

Article

Evaluation of a novel fully automated and ELISA- based assays for detecting anti- SARS- CoV-2 neutralizing antibodies

2022-06-21

Abstract excerpt

<h4>Background: </h4> Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity in infected and vaccinated subjects. The current gold standard relies on pseudovirus neutralization tests which require sophisticated skills and facilities. Alternatively, recent competitive immunoassays measuring anti-S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c22c9ee1-cae7-5711-b846-7cc1874586b4
DOI
10.21203/rs.3.rs-1718587/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of a novel fully automated and ELISA- based assays for detecting anti- SARS- CoV-2 neutralizing antibodiesDOI 10.21203/rs.3.rs-1718587/v1
IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity
Homogeneous Surrogate Virus Neutralization Assay to Rapidly Assess Neutralization Activity of Anti-SARS-CoV-2 AntibodiesSemantic proximity
Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2Semantic proximity
Rapid, High Throughput, Automated Detection Of SARS-Cov-2 Neutralizing Antibodies Against Native-Like Vaccine And Delta Variant Spike TrimersSemantic proximity
SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalenceSemantic proximity
Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjectsSemantic proximity
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2Semantic proximity
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesSemantic proximity
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunitySemantic proximity
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimersSemantic proximity
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Semantic proximity
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity
Select a neighboring publication to make it the new centre.